← Leaderboards
Matthew Brent Laurens
University Of Maryland Baltimore
$1,300,240
Attributed
$1,735,708
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $870.9K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,735,708 · 2
By mechanism
U01$1,484,912 · 1
R34$250,796 · 1
Top collaborators
- Christopher V. Plowe1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Miriam K Laufer$32,646,632
- Christopher V. Plowe$27,953,996
- Shannon Takala Harrison$7,286,212
- Joana Carneiro Da Silva$11,063,955
- Rena Lapidus$1,044,450
Others in their field
Other Emerging Leaders on “Parasites”
- Donna Muzny · Baylor College Of Medicine$7,660,082
- Jakob H. Von Moltke · University Of Washington$6,273,454
- Yosuke Kumamoto · Rbhs-New Jersey Medical School$5,977,607
- Jennifer Manuzak · University Of Washington$5,904,701
- Kayode K Ojo · University Of Washington$5,773,228
- Tuan Manh Tran · Indiana University Indianapolis$5,769,610
Research focus
ParasitesSporozoite VaccineImmune ResponseMalaria VaccinesPreventSafetyClinical DevelopmentDoseInfectionMalaria TransmissionPlasmodium FalciparumPlasmodium Falciparum VaccineRadiationAreaAttenuatedCharacteristicsBloodClinical TrialsBurkina FasoImmunogenicityMalariaMalaria InfectionAdultVaccination
Grant awards (3)
Safety, immunogencity, and efficacy of PfSPZ LARC2 malaria vaccine in malaria-exposed adults and children$250,796
R34 · FY2024 · AI · contact PI
Safety and efficacy of PfSPZ malaria vaccine in malaria-exposed adults$613,976
U01 · FY2018 · AI · contact PI
Safety and efficacy of PfSPZ malaria vaccine in malaria-exposed adults$870,936
U01 · FY2017 · AI